Literature DB >> 20425222

The role of CT and MRI in the emergency evaluation of persons with suspected stroke.

Chelsea S Kidwell1, Max Wintermark.   

Abstract

As a growing number of therapeutic treatment options for acute stroke are being introduced, multimodal acute neuroimaging is assuming a growing role in the initial evaluation and management of patients. Multimodal neuroimaging, using either a CT or MRI approach, can identify the type, location, and severity of the lesion (ischemia or hemorrhage); the status of the cerebral vasculature; the status of cerebral perfusion; and the existence and extent of the ischemic penumbra. Both acute and long-term treatment decisions for stroke patients can then be optimally guided by this information.

Entities:  

Mesh:

Year:  2010        PMID: 20425222     DOI: 10.1007/s11910-009-0075-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  48 in total

1.  Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).

Authors:  V Larrue; R von Kummer R; A Müller; E Bluhmki
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

2.  Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke.

Authors:  Max Wintermark; Nancy J Fischbein; Wade S Smith; Nerissa U Ko; Marcel Quist; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

3.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

4.  MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.

Authors:  Martin Köhrmann; Eric Jüttler; Jochen B Fiebach; Hagen B Huttner; Stefan Siebert; Christian Schwark; Peter A Ringleb; Peter D Schellinger; Werner Hacke
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

5.  Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients.

Authors:  Jessica C Tan; William P Dillon; Songling Liu; Felix Adler; Wade S Smith; Max Wintermark
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

6.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

7.  Determinants of intracerebral hemorrhage growth: an exploratory analysis.

Authors:  Joseph P Broderick; Michael N Diringer; Michael D Hill; Nikolai C Brun; Stephan A Mayer; Thorsten Steiner; Brett E Skolnick; Stephen M Davis
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

8.  Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.

Authors:  Osama O Zaidat; Jose I Suarez; Concepcion Santillan; Jeffrey L Sunshine; Robert W Tarr; Vanessa H Paras; Warren R Selman; Dennis M D Landis
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

9.  Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging.

Authors:  Oliver C Singer; Marek C Humpich; Jens Fiehler; Gregory W Albers; Maarten G Lansberg; Andiras Kastrup; Alex Rovira; David S Liebeskind; Achim Gass; Charlotte Rosso; Laurent Derex; Jong S Kim; Tobias Neumann-Haefelin
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

10.  Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.

Authors:  Maarten G Lansberg; Vincent N Thijs; Roland Bammer; Stephanie Kemp; Christine A C Wijman; Michael P Marks; Gregory W Albers
Journal:  Stroke       Date:  2007-06-14       Impact factor: 7.914

View more
  6 in total

Review 1.  Neuroimaging of cerebral ischemia and infarction.

Authors:  Carlos Leiva-Salinas; Max Wintermark; Chelsea S Kidwell
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Diagnostic yield of emergency department arch-to-vertex CT angiography in patients with suspected acute stroke.

Authors:  A R Deipolyi; L M Hamberg; R G Gonzaléz; J A Hirsch; G J Hunter
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-25       Impact factor: 3.825

3.  Construction of a Cerebral Hemorrhage Test System Operated in Real-time.

Authors:  Gen Li; Jian Sun; Ke Ma; Qingguang Yan; Xiaolin Zheng; Mingxin Qin; Gui Jin; Xu Ning; Wei Zhuang; Hua Feng; Shiyuwei Huang
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

Review 4.  Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage.

Authors:  Colin B Josephson; Philip M White; Ashma Krishan; Rustam Al-Shahi Salman
Journal:  Cochrane Database Syst Rev       Date:  2014-09-01

5.  The impact of Magnetic Resonance Imaging (MRI) on ischemic stroke detection and incidence: minimal impact within a population-based study.

Authors:  Dawn Kleindorfer; Jane Khoury; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Matthew L Flaherty; Opeolu Adeoye; Simona Ferioli; Pooja Khatri; Brett M Kissela
Journal:  BMC Neurol       Date:  2015-09-25       Impact factor: 2.474

Review 6.  Current approaches and advances in the imaging of stroke.

Authors:  Pragati Kakkar; Tarun Kakkar; Tufail Patankar; Sikha Saha
Journal:  Dis Model Mech       Date:  2021-12-07       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.